Simon Hill MSc, BSc @theproof · 08 Aug 2026
Repatha is a pcsk9 inhibitor (drug name evolocumab). Lowers ApoB by blocking a natural protein called PCSK9 in circulation. Blocking this protein results in a greater number of LDL receptors on the liver which in turn results in greater clearance of ApoB containing lipoproteins
8 746Views
62Likes
0Reposts
4Replies
0Quotes
40Bookmarks
Is that a lot?
3.75×vs this author's median2 331 views is typical
62Percentile for this authorof 8 recent posts
3.66×vs 10K–100K median2 392 views is typical
23.56%Reachviews ÷ followers
0.76%Engagement rateof viewers reacted